University Hospitals Is First in Cleveland To Offer GT Medical Technologies' New Targeted Therapy for Brain Tumors
University Hospitals Is First in Cleveland To Offer GT Medical Technologies' New Targeted Therapy for Brain Tumors GammaTile® Therapy Is Shown To Slow Brain Tumor Progression, Designed To Improve Patient and Caregiver Quality of Life News provided by Share this article Share this article CLEVELAND, Feb. 17, 2021 /PRNewswire/ -- A University Hospitals Cleveland Medical Center neurosurgeon is among the first in the region to begin offering GammaTile ® Therapy, a new approach to treating brain tumors. GammaTile Therapy is an FDA-cleared, Surgically Targeted Radiation Therapy (STaRT) that is de...
Source: prnewswire.com